Search results
Regeneron Bulls, Bears Clash: Will Biotech Get Eylea Mojo Back?
Investor's Business Daily· 8 months agoRegeneron Pharmaceuticals is the IBD Stock of the Day as the biotech giant trades near an all-time...
Declining Stock and Solid Fundamentals: Is The Market Wrong About Regeneron Pharmaceuticals, Inc....
Simply Wall St. via Yahoo Finance· 1 year agoIt is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent...
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?
Simply Wall St. via Yahoo Finance· 1 month agoKey Insights Regeneron Pharmaceuticals' estimated fair value is US$1,903 based on 2 Stage Free Cash...
Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoIn the latest trading session, Regeneron (REGN) closed at $800.73, marking a +0.33% move from the...
Regeneron (REGN) Is Up 3.97% in One Week: What You Should Know
Zacks via Yahoo Finance· 5 months agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 years agoRegeneron (REGN) possesses the right combination of the two key ingredients for a likely earnings...
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock Is Going Strong: Is the Market Following...
Simply Wall St. via Yahoo Finance· 4 months agoRegeneron Pharmaceuticals (NASDAQ:REGN) has had a great run on the share market with its stock up by...
Regeneron (REGN) Recently Broke Out Above the 20-Day Moving Average
Zacks via Yahoo Finance· 2 years agoRegeneron (REGN) is looking like an interesting pick from a technical perspective, as the company...
Down -8.24% in 4 Weeks, Here's Why Regeneron (REGN) Looks Ripe for a Turnaround
Zacks via Yahoo Finance· 2 months agoRegeneron (REGN) has become technically an oversold stock now, which implies exhaustion of the heavy...
Are Strong Financial Prospects The Force That Is Driving The Momentum In Regeneron Pharmaceuticals,...
Simply Wall St. via Yahoo Finance· 9 months agoRegeneron Pharmaceuticals' (NASDAQ:REGN) stock is up by a considerable 19% over the past three...